Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Mortimer

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Cancers|July 12, 2025
Efficacy of Metastasis-Directed Radiation Therapy to Prolong Systemic Therapy for Patients with Oligoprogressive Metastatic Breast CancerAlexis LeVee, Hannah Young, Stephanie Yoon, et al.
Oncotarget|February 6, 2019
Molecular subtypes of triple-negative breast cancer in women of different race and ethnicityYuan Chun Ding, Linda Steele, Charles Warden, et al.
JCO Clinical Cancer Informatics|January 14, 2025
Validation of Clinical Dynamic Contrast-Enhanced Magnetic Resonance Imaging Perfusion Modeling and Neoadjuvant Chemotherapy Response Prediction in Breast Cancer Using <sup>18</sup>FDG and <sup>64</sup>Cu-DOTA-Trastuzumab Positron Emission Tomography StudiesJohn Whitman, Vikram Adhikarla, Lusine Tumyan, et al.
Scientific Reports|April 5, 2020
Effect of High Intensity Interval Training on Matrix Metalloproteinases in Women with Breast Cancer Receiving Anthracycline-Based ChemotherapyKyuwan Lee, Irene Kang, Wendy J Mack, et al.
BMC Cancer|July 5, 2019
Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trialKyuwan Lee, Irene Kang, Wendy J Mack, et al.
The Oncologist|November 9, 2025
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancerAlexis LeVee, Austin Kordic, Nora Ruel, et al.
The Oncologist|July 11, 2026
GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort studyRebecca A Nelson, Ying-Chuen Lai, Sung H Kil, et al.
Journal of Surgical Oncology|August 11, 2006
The efficacy of breast MRI in predicting breast conservation therapySarah Blair, Michele McElroy, Michael S Middleton, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2007
Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironmentYunchao Chang, Masahiko Zuka, Pablo Perez-Pinera, et al.
Research Square|July 10, 2026
Multi-state modeling associates proliferation genes with early estrogen receptor-positive breast cancer recurrence and survivalYongzhe Wang, Christine Quinones, Irene Kang, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Cancers|July 12, 2025
Efficacy of Metastasis-Directed Radiation Therapy to Prolong Systemic Therapy for Patients with Oligoprogressive Metastatic Breast CancerAlexis LeVee, Hannah Young, Stephanie Yoon, et al.
Oncotarget|February 6, 2019
Molecular subtypes of triple-negative breast cancer in women of different race and ethnicityYuan Chun Ding, Linda Steele, Charles Warden, et al.
JCO Clinical Cancer Informatics|January 14, 2025
Validation of Clinical Dynamic Contrast-Enhanced Magnetic Resonance Imaging Perfusion Modeling and Neoadjuvant Chemotherapy Response Prediction in Breast Cancer Using <sup>18</sup>FDG and <sup>64</sup>Cu-DOTA-Trastuzumab Positron Emission Tomography StudiesJohn Whitman, Vikram Adhikarla, Lusine Tumyan, et al.
Scientific Reports|April 5, 2020
Effect of High Intensity Interval Training on Matrix Metalloproteinases in Women with Breast Cancer Receiving Anthracycline-Based ChemotherapyKyuwan Lee, Irene Kang, Wendy J Mack, et al.
BMC Cancer|July 5, 2019
Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trialKyuwan Lee, Irene Kang, Wendy J Mack, et al.
The Oncologist|November 9, 2025
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancerAlexis LeVee, Austin Kordic, Nora Ruel, et al.
The Oncologist|July 11, 2026
GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort studyRebecca A Nelson, Ying-Chuen Lai, Sung H Kil, et al.
Journal of Surgical Oncology|August 11, 2006
The efficacy of breast MRI in predicting breast conservation therapySarah Blair, Michele McElroy, Michael S Middleton, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2007
Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironmentYunchao Chang, Masahiko Zuka, Pablo Perez-Pinera, et al.
Research Square|July 10, 2026
Multi-state modeling associates proliferation genes with early estrogen receptor-positive breast cancer recurrence and survivalYongzhe Wang, Christine Quinones, Irene Kang, et al.
Pageof 11